Hers vs Push Health
Hers costs $751 less a month, and both sell semaglutide.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Hers
Best for: coverage in all 50 states, which most sellers will not confirm
Visit Hers →
If you are choosing between Hers and Push Health, the first difference is cost: Hers is $751 a month cheaper at the entry price. Both prescribe semaglutide, so moving from one to the other would not change your drug. Hers leads our six-part score, 7.0 to 5.6.
Hers vs Push Health price
Hers is the cheaper way in: $199 a month against $950 a month at Push Health. That is $751 less each month (79% lower), or about $9,012 over a year of treatment.
Drug by drug: Semaglutide is cheaper at Hers ($199 a month vs $950 a month).
Medications and formats
Both sell semaglutide; only Hers lists tirzepatide.
On format, Hers prices compounded injections and brand-name pens, while Push Health prices brand-name pens.
Where each one treats patients
Hers lists 50 states, and Push Health does not publish where it ships.
Pricing
Hers
Brand Zepbound from $299/mo medication-only; requires Hers Weight Loss Membership ($149/mo)
Push Health
Ozempic / brand
What each price covers
Hers' price also covers the medication itself, which Push Health does not claim.
Hers is silent on shipping and lab work.
Push Health does not say what its price includes.
That matters most for the drug: unless Push Health confirms otherwise, budget for medication on top of its listed price.
Hers
Covered by the monthly price
Medication
In the price
Clinician visits
Charged on top
Shipping
Not stated
Lab work
Not stated
Coaching
Charged on top
Push Health
Inclusions not disclosed.
Where each one scores higher
Overall, Hers scores 7.0 and Push Health 5.6 out of 10.
Hers is stronger on effectiveness (10.0 vs 9.0), user experience (8.0 vs 3.0), trust & safety (8.5 vs 4.0) and accessibility (10.0 vs 5.0).
Push Health is stronger on value (5.3 vs 3.0) and support (5.0 vs 3.0).
Hers
7.0/10
Push Health
5.6/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
FDA warning letters
Neither Hers nor Push Health has an FDA warning letter on record with us.
Features & Coverage
| Feature | Hers | Push Health |
|---|---|---|
| Starting Price | ✓$199/mo | $950/mo |
| Features | 2 features | ✓5 features |
| States Available | 50 | Not disclosed |
| Compounded | ✓ Yes | — |
| Brand Name | ✓ Yes | ✓ Yes |
| FSA/HSA Accepted | — | — |
| FDA Warning Letters | None | None |
About Hers
Hers is the women-focused telehealth brand from Hims and Hers. It sells compounded semaglutide on a 6-month plan.
Read our full Hers review →About Push Health
A 55,000+ pharmacy network sits behind Push Health, which writes brand-name GLP-1 prescriptions, Mounjaro, Zepbound, and Ozempic, and routes them through it. The platform is a large US telehealth operation and holds LegitScript certification.
Read our full Push Health review →Pros & Cons
Hers
What we like
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes the medication
- Serves all 50 states
- We found no FDA warning letters issued to Hers
Watch-outs
- Not included in the monthly price: clinician visits, coaching
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide is compounded rather than FDA-approved, so it has not been reviewed by the agency for safety, effectiveness or manufacturing quality
Push Health
What we like
- Semaglutide costs $950 a month, close to the $990 median for brand-name semaglutide across the sellers we compare
- We found no FDA warning letters issued to Push Health
Watch-outs
- You only see a price after finishing the medical intake, so you cannot compare costs before sharing health information
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
Our Verdict
Hers wins this one, 7.0 to 5.6, above all for coverage in all 50 states, which most sellers will not confirm. It also costs $751 less each month than Push Health. Push Health fits better if semaglutide from $950/month is your priority.
Choose Hers if…
You want coverage in all 50 states, which most sellers will not confirm and an opening price near $199 a month.
Choose Push Health if…
You want semaglutide from $950/month and an opening price near $950 a month.
Ready to start? GLP-1 providers we have vetted
Telehealth providers, vetted by us, prescribing GLP-1 online.
Vetted by our editors · no insurance required
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Sesame Care
Oral orforglipron alongside the injectables
From $59/mo
Get started →Collective
Flat any-dose pricing, if you can absorb a $199 annual membership on top
From $59/mo
Get started →Found
Tirzepatide at $169/month, 37% below the typical price
From $149/mo
Get started →Hers vs Push Health: FAQ
Close alternatives to Hers and Push Health
- Hers vs Hims
- Hers vs Noom
- Hers vs Care Bare Rx
- Hers vs Concierge MD LA
- Push Health vs JumpstartMD
- Push Health vs Marek Health
Or see the full category ranking.
Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.